A new report from the Commonwealth Fund says the Trump administration’s proposed regulations encouraging the sale of various health insurance plans that are noncompliant with the Affordable Care Act (ACA) is likely to leave the marketplaces with a smaller group of enrollees who are sicker, unless states step in to consider “regulatory options” to protect the individual insurance market.
A new report from the Commonwealth Fund said the Trump administration’s proposed regulations encouraging the sale of various health insurance plans that are noncompliant with the Affordable Care Act (ACA) is likely to leave the marketplaces with a smaller group of enrollees who are sicker, unless states step in to consider “regulatory options” to protect the individual insurance market.
The problem is likely to get worse in 2019 when the individual mandate ends next year, the report said.
The report, from both the Commonwealth Fund and Georgetown University’s Health Policy Institute, looked at short-term health plans, association health plans (AHPs), and healthcare sharing ministries (HCSMs), and the actions states have taken to regulate them.
These plans don’t have to meet many—or, sometimes, any­—of the ACA’s federal consumer protections. These plans may appeal to healthy consumers because of their low upfront costs. But they often cover fewer services and expose people to high out-of-pocket costs when they get sick.
The report said some options also increase consumers’ risk of being defrauded or enrolling in a financially unstable plan. In addition, the report said state oversight is weak. Although states have broad authority to regulate these other types of plans, most do not.
The ACA did not limit states’ power to regulate above these minimum standards, the authors of the Commonwealth Fund report said. Nor did the ACA limit states’ capacity to regulate health coverage that falls outside the scope of federal insurance law.
While no state fully protects its individual health insurance market from the effects of these skimpier plans, the report said, it called out Massachusetts and New York as two examples that have taken steps to limit their availability and protect their ACA marketplaces. They have restricted the availability of underwritten short-term policies that don’t meet comprehensive benefit standards, such as coverage for mental health services, prescription drugs, and maternity care. Several other states tightly restrict the duration of such plans.
Decisions like these will likely have a significant effect on the accessibility and affordability of individual health insurance and the stability of markets.
The new health insurance options being proposed by the administration include:
Reference
Lucia K, Giovannelli J, Corlette S, et al. State regulation of coverage options outside of the Affordable Care Act: limiting the risk to the individual market. The Commonwealth Fund. http://www.commonwealthfund.org/publications/fund-reports/2018/mar/state-regulation-coverage-options-outside-aca. Published March 29, 2018. Accessed March 29, 2018.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
What We’re Reading: Affordable Home Care; Mycoplasma Infections Rise; Opioid Crisis Settlement
December 4th 2023Families struggle to find affordable, reliable home health aides; reports of increased pediatric pneumonia cases; legal battle ensues over Purdue Pharma’s bankruptcy settlement.
Read More